Khushnuma Mullanfiroze

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy.

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy.

Journal: Blood advances
Published: July 10, 2023

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

Journal: Blood
Published: March 31, 2023

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.

Journal: Blood advances
Published: October 28, 2022

Prevalence of adsorbed A antigen onto donor-derived group O red cells in children following stem cell transplantation: A single-centre evaluation.

Prevalence of adsorbed A antigen onto donor-derived group O red cells in children following stem cell transplantation: A single-centre evaluation.

Journal: Vox sanguinis
Published: September 27, 2022

Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases.

Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases.

Journal: Bone marrow transplantation
Published: July 21, 2022

CD34+-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy.

CD34+-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy.

Journal: Blood advances
Published: March 14, 2022

Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.

Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.

Journal: British journal of haematology
Published: July 29, 2021

Azacitidine and venetoclax for post-transplant relapse in a case of CBFA2T3/GLIS2 childhood acute myeloid leukaemia.

Azacitidine and venetoclax for post-transplant relapse in a case of CBFA2T3/GLIS2 childhood acute myeloid leukaemia.

Journal: Pediatric blood & cancer
Published: May 08, 2021

Valgancyclovir-induced encephalopathy in a child after hematopoietic stem cell transplant.

Valgancyclovir-induced encephalopathy in a child after hematopoietic stem cell transplant.

Journal: Pediatric blood & cancer
Published: February 02, 2019

Cytomegalovirus reactivation posthematopoietic stem cell transplantation (HSCT) and type of graft: A step toward rationalizing CMV testing and positively impacting the economics of HSCT in developing countries.

Cytomegalovirus reactivation posthematopoietic stem cell transplantation (HSCT) and type of graft: A step toward rationalizing CMV testing and positively impacting the economics of HSCT in developing countries.

Journal: Pediatric blood & cancer
Published: February 07, 2017

Hydrocephalus in tuberculous meningitis--how fast does it develop?

Hydrocephalus in tuberculous meningitis--how fast does it develop?

Journal: Scandinavian journal of infectious diseases
Published: April 08, 2014

Profile of HIV and multidrug-resistant tuberculosis in orphans living in orphanages in Mumbai, Maharashtra, India.

Profile of HIV and multidrug-resistant tuberculosis in orphans living in orphanages in Mumbai, Maharashtra, India.

Journal: Indian journal of sexually transmitted diseases and AIDS
Published: November 01, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026